|
RBL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.955600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.906970E-01 |
| Normal-vs-Stage2 |
4.061400E-01 |
| Normal-vs-Stage3 |
5.034200E-02 |
| Normal-vs-Stage4 |
5.772000E-01 |
| Stage1-vs-Stage2 |
1.210170E-01 |
| Stage1-vs-Stage3 |
1.876300E-02 |
| Stage1-vs-Stage4 |
9.476600E-01 |
| Stage2-vs-Stage3 |
3.848200E-01 |
| Stage2-vs-Stage4 |
3.591200E-01 |
| Stage3-vs-Stage4 |
1.347450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.408000E-01 |
| Normal-vs-AfricanAmerican |
6.801400E-01 |
| Normal-vs-Asian |
9.289800E-01 |
| Caucasian-vs-AfricanAmerican |
4.811200E-01 |
| Caucasian-vs-Asian |
9.715600E-01 |
| AfricanAmerican-vs-Asian |
8.301200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.138950E-01 |
| Normal-vs-Female |
2.542200E-03 |
| Male-vs-Female |
2.184200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.514400E-01 |
| Normal-vs-Extreme_Weight |
6.220800E-03 |
| Normal-vs-Obese |
1.136210E-01 |
| Normal-vs-Extreme_Obese |
6.306300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.522600E-01 |
| Normal_Weight-vs-Obese |
1.359960E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.188800E-01 |
| Extreme_Weight-vs-Obese |
2.359200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.215800E-01 |
| Obese-vs-Extreme_Obese |
1.008450E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.128190E-01 |
| Normal-vs-Age(41-60Yrs) |
1.366640E-01 |
| Normal-vs-Age(61-80Yrs) |
1.760560E-01 |
| Normal-vs-Age(81-100Yrs) |
2.169800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.329600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.510100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.181700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.783680E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.279800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.188770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.174560E-01 |
| Normal-VS-Type2 PRCC |
9.418600E-01 |
| Normal-VS-KIRP CIMP |
5.909500E-02 |
| Normal-VS-Unclassified PRCC |
1.874070E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.167400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.096300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.622900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.062000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.607900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.842010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.732400E-01 |
| Normal-vs-N1 |
3.930200E-02 |
| Normal-vs-N2 |
8.175600E-01 |
| N0-vs-N1 |
2.329700E-02 |
| N0-vs-N2 |
9.549400E-01 |
| N1-vs-N2 |
3.324200E-01 |
|
|
